Kaplan El
Impact in
-
- Streptococcal Infections and Treatments
-
- Antimicrobial Resistance in Staphylococcus
- Otolaryngology and Infectious Diseases
Papers in
-
- Streptococcal Infections and Treatments 12
- Neonatal and Maternal Infections 3
-
- Infective Endocarditis Diagnosis and Management 8
- Co-authors
- M A Gerber (2 shared papers)Schwartz Rh (1 shared paper)A L Bisno (1 shared paper)Leon Gordis (1 shared paper)Richard R. Facklam (1 shared paper)Samuel Refetoff (1 shared paper)CHATRCHAI WATANAKUNAKORN (1 shared paper)John Kim (1 shared paper)
- Journals
- Circulation (1 paper)European Journal of Endocrinology (1 paper)PubMed (14 papers)
- Partner nations
- United StatesTunisiaFrance
In The Last Decade
Kaplan El
17 papers receiving 294 citations
Peers
Comparison fields: 5 of 56
- Public Health, Environmental and Occupational Health 187
- Infectious Diseases 105
- Epidemiology 153
- Clinical Biochemistry 24
- Cardiology and Cardiovascular Medicine 66
Countries citing papers authored by Kaplan El
This map shows the geographic impact of Kaplan El's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaplan El with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaplan El more than expected).
Fields of papers citing papers by Kaplan El
This network shows the impact of papers produced by Kaplan El. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaplan El. The network helps show where Kaplan El may publish in the future.
Co-authors
The 21 scholars most cited alongside Kaplan El, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. | 1984 | 155 |
| 2 | 1977 | 64 | |
| 3 | Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association. | 1989 | 49 |
| 4 | 2004 | 24 | |
| 5 | Characterization of group A streptococci isolated in Kuala Lumpur, Malaysia. | 1995 | 12 |
| 6 | Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young. | 1981 | 11 |
| 7 | Rheumatic fever in Minnesota. Current assessment of reported cases. | 1978 | 8 |
| 8 | Acute rheumatic fever in Tunisia. Serotypes of group A streptococci associated with rheumatic fever. | 1997 | 8 |
| 9 | Restriction enzyme analysis (REA) of group A streptococcal (GAS) M-serotypes 1, 3, and 28. A comparison of isolates from severe systemic infections (SSI) and from uncomplicated pharyngitis (UP): epidemiologic and pathogenetic implications. | 1997 | 4 |
| 10 | A pilot study for the primary prevention of rheumatic fever in Kosrae, Federated States of Micronesia. | 2010 | 3 |
| 11 | Characterization of Streptococcus pyogenes in Hong Kong | 1999 | 3 |
| 12 | Cardiovascular disease in children. Reflections on the last half century and expectations for the future. | 1991 | 2 |
| 13 | The group A beta hemolytic streptococcus. No longer just a nuisance? | 1994 | 1 |
| 14 | Epidemiology and pathogenesis of acute rheumatic fever. Recent concepts. | 1975 | 1 |
| 15 | Rheumatic fever in the United States: no longer a disease of the past. | 1988 | 1 |
| 16 | Antibiotic prophylaxis for bacterial endocarditis. Necessity or tradition? | 1973 | 1 |
| 17 | Forty years of cardiac disease in children. Progress and problems--first of three parts. | 1991 | 1 |
About Kaplan El
Kaplan El is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology, Surgery, Microbiology and Infectious Diseases, having authored 17 papers that have together received 348 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (12 papers), Infective Endocarditis Diagnosis and Management (8 papers), Neonatal and Maternal Infections (3 papers), Kawasaki Disease and Coronary Complications (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Inflammasome and immune disorders (2 papers), Coronary Artery Anomalies (1 paper) and Actinomycetales infections and treatment (1 paper). The work is most often cited by research in Public Health, Environmental and Occupational Health (187 citations), Infectious Diseases (105 citations), Epidemiology (153 citations), Clinical Biochemistry (24 citations) and Cardiology and Cardiovascular Medicine (66 citations). Kaplan El has collaborated with scholars based in United States, Tunisia and France. Frequent co-authors include M A Gerber, Schwartz Rh, A L Bisno, Leon Gordis, Richard R. Facklam, Samuel Refetoff, CHATRCHAI WATANAKUNAKORN, John Kim, Sirimon Reutrakul and Farida Jamal. Their work appears in journals such as Circulation, European Journal of Endocrinology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.